Clinical trial
Open-label Treatment Extension Study for Patients Who Complete Study…
NCT00230490 · Bausch Health Americas, Inc., Industry · Terminated
Key facts
| NCT number | NCT00230490 |
|---|---|
| Title | Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201 |
| Official title | Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201 |
| Lead sponsor | Bausch Health Americas, Inc., Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis B, Chronic |
| Intervention type | Drug |
| Interventions | pradefovir mesylate, adefovir dipivoxyl |
| Enrollment | 150 |
| Start date | Jun 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Sep 30, 2005 |
| Last update posted | Nov 29, 2019 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: